Immatics (IMTX) Change in Intangibles (2019 - 2025)
Immatics recorded quarterly Change in Intangibles of -$66350.5 in Q4 2025, up 54.91% quarter-over-quarter from -$147154.8 in Q2 2025, and down 3.49% year-over-year from -$68746.6 in Q4 2024.
Immatics' Change in Intangibles history runs 7 years deep, the most recent figure standing at -$66350.5 for Q4 2025.
- In Q4 2025, Change in Intangibles fell 3.49% year-over-year to -$66350.5; the TTM figure through Dec 2025 stood at -$276618.3 (down 23.76% YoY), while the FY2025 annual figure was -$279063.4, down 25.55% from the prior year.
- Change in Intangibles came in at -$66350.5 for Q4 2025 at Immatics, up from -$147154.8 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $169828.5 in Q4 2023 to a low of -$462440.2 in Q2 2021.
- A 5-year average of -$91333.2 and a median of -$65233.1 in 2024 frame the typical range for Change in Intangibles.
- On a YoY basis, Change in Intangibles climbed as much as 164.77% in 2023 and fell as far as 3624.8% in 2023.
- Immatics' Change in Intangibles stood at -$73214.1 in 2021, then tumbled by 258.13% to -$262203.6 in 2022, then surged by 164.77% to $169828.5 in 2023, then plunged by 137.75% to -$64115.7 in 2024, then fell by 3.49% to -$66350.5 in 2025.
- According to Business Quant data, Change in Intangibles over the past three periods registered -$66350.5, -$147154.8, and -$63113.1 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | -66,350.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66,350.48 |
| Dec 31, 2025 | -66,350.48 |
| Jun 30, 2025 | -147,154.76 |
| Jun 30, 2025 | -147,154.76 |
| Mar 31, 2025 | -63,113.07 |
| Mar 31, 2025 | -63,113.07 |
| Dec 31, 2024 | -64,115.72 |
| Dec 31, 2024 | -64,115.72 |
| Jun 30, 2024 | -157,225.59 |
| Jun 30, 2024 | -157,225.59 |
| Mar 31, 2024 | -2,172.72 |
| Mar 31, 2024 | -2,172.72 |
| Dec 31, 2023 | 169,828.51 |
| Dec 31, 2023 | 169,828.51 |
| Sep 30, 2023 | -4,354.36 |
| Sep 30, 2023 | -4,354.36 |
| Jun 30, 2023 | -158,982.96 |
| Jun 30, 2023 | -158,982.96 |
| Mar 31, 2023 | -8,586.73 |
| Mar 31, 2023 | -8,586.73 |
| Dec 31, 2022 | -262,203.57 |
| Dec 31, 2022 | -262,203.57 |
| Sep 30, 2022 | -215,770.71 |
| Sep 30, 2022 | -215,770.71 |
| Jun 30, 2022 | -4,268.23 |
| Jun 30, 2022 | -4,268.23 |
| Mar 31, 2022 | -2,244.68 |
| Mar 31, 2022 | -2,244.68 |
| Dec 31, 2021 | -73,214.14 |
| Dec 31, 2021 | -73,214.14 |
| Sep 30, 2021 | -114,390.87 |
| Sep 30, 2021 | -114,390.87 |
| Jun 30, 2021 | -462,440.23 |
| Jun 30, 2021 | -462,440.23 |
| Mar 31, 2021 | -7,237.42 |
| Mar 31, 2021 | -7,237.42 |
| Dec 31, 2020 | -21,461.22 |
| Dec 31, 2020 | -21,461.22 |
| Sep 30, 2020 | -58,403.86 |
| Sep 30, 2020 | -58,403.86 |
| Jun 30, 2020 | -34,145.26 |
| Jun 30, 2020 | -34,145.26 |
| Mar 31, 2020 | -5,519.70 |
| Mar 31, 2020 | -5,519.70 |
| Dec 31, 2019 | -34,313.52 |
| Dec 31, 2019 | -34,313.52 |
| Sep 30, 2019 | -2,225.46 |
| Sep 30, 2019 | -2,225.46 |